MedNet Solutions Again Recognized as one of the Fastest Growing US Companies

MINNETONKA, Minn., Sept. 9 For the second consecutiveyear, MedNet Solutions, a leading healthcare technology company specializingin clinical study management systems, has been recognized by Inc. magazine asbeing among the United States' fastest growing private organizations. Withconsistently strong growth over the past four years, MedNet was thethirty-sixth fastest growing company in the Twin Cities metro area, and fifthamong healthcare-related software companies in the Midwest.

"MedNet Solutions is proud to once again be on the 'Inc. 5000' list,"stated John M. (Rob) Robertson, MedNet Solutions' President and CEO. "Thisachievement is a testament to the strength of our technology, as well as theexpertise and commitment of our team. It's especially gratifying that MedNethas achieved this remarkable revenue growth while consistently maintainingprofitability year after year. Our growth and profitability, combined withour outstanding customer and industry relationships, means that MedNet is wellpositioned for long-term success."

MedNet Solutions is a leading eClinical technology solutions companysupporting the pharmaceutical, medical device and biotechnology industries.Applying Critical Insight, Proven Technology, and Unwavering Support, MedNethelps sponsors and CROs alike deploy efficient and successful clinical studiesand registries of all phases and types. Since 2000, MedNet has successfullysupported over 50 major customer organizations on projects spanning 6continents and more than 40 countries, with a highly configurable and easy tolearn web-based eClinical solution. MedNet delivers a superior customerexperience from beginning to end. For more information, please visithttp://www.mednetstudy.com.Contact Information: Dirk H. Nelson Marketing Manager 601 Carlson Parkway, Suite 605 Minnetonka, MN 55305 USA (763) 258-2735

SOURCE MedNet Solutions

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...